BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 18003719)

  • 1. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
    Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor.
    Schwertz H; Carter JM; Abdudureheman M; Russ M; Buerke U; Schlitt A; Müller-Werdan U; Prondzinsky R; Werdan K; Buerke M
    Proteomics; 2007 Dec; 7(24):4579-88. PubMed ID: 18072194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.
    Punn A; Mockridge JW; Farooqui S; Marber MS; Heads RJ
    Biochem J; 2000 Sep; 350 Pt 3(Pt 3):891-9. PubMed ID: 10970806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.
    Szokodi I; Kerkelä R; Kubin AM; Sármán B; Pikkarainen S; Kónyi A; Horváth IG; Papp L; Tóth M; Skoumal R; Ruskoaho H
    Circulation; 2008 Oct; 118(16):1651-8. PubMed ID: 18824646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluR6-containing KA receptor mediates the activation of p38 MAP kinase in rat hippocampal CA1 region during brain ischemia injury.
    Chen J; Li C; Pei DS; Han D; Liu XM; Jiang HX; Wang XT; Guan QH; Wen XR; Hou XY; Zhang GY
    Hippocampus; 2009 Jan; 19(1):79-89. PubMed ID: 18680160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats.
    Omura T; Yoshiyama M; Shimada T; Shimizu N; Kim S; Iwao H; Takeuchi K; Yoshikawa J
    J Mol Cell Cardiol; 1999 Jun; 31(6):1269-79. PubMed ID: 10371701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
    Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart.
    Wang M; Tsai BM; Turrentine MW; Mahomed Y; Brown JW; Meldrum DR
    Ann Thorac Surg; 2005 Dec; 80(6):2235-41. PubMed ID: 16305880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
    Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
    Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
    Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
    Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis.
    Tao L; Jiao X; Gao E; Lau WB; Yuan Y; Lopez B; Christopher T; RamachandraRao SP; Williams W; Southan G; Sharma K; Koch W; Ma XL
    Circulation; 2006 Sep; 114(13):1395-402. PubMed ID: 16966583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
    Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.